Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at the drugs defactinib with VS-6766 for all cancers (FRAME)

Overview

Cancer types:

All cancer types, Bowel (colorectal) cancer, Lung cancer, Non small cell lung cancer (NSCLC), Ovarian cancer, Pancreatic cancer, Womb (uterine or endometrial) cancer

Status:

Closed

Phase:

Phase 1

Details

This trial is looking at defactinib with VS-6766 for solid cancers. A is any cancer apart from leukaemia, lymphoma and myeloma.

It is open to people who can’t have or don’t want to have the for their cancer.

Recruitment start: 6 December 2017

Recruitment end: 31 January 2023

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Udai Banerji

Supported by

Institute of Cancer Research (ICR)

Chugai Pharma UK Ltd

Verastem Inc

Last reviewed: 31 January 2023

CRUK internal database number: 17248

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.